{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:23:05Z","timestamp":1761920585493,"version":"3.37.3"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T00:00:00Z","timestamp":1558483200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T00:00:00Z","timestamp":1558483200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100005224","name":"Deutsches Zentrum f\u00fcr Neurodegenerative Erkrankungen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005224","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Diabetol"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1007\/s00592-019-01332-7","type":"journal-article","created":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T19:02:50Z","timestamp":1558551770000},"page":"995-1003","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Different treatment forms of type II diabetes and the risk of dementia in German health claims data"],"prefix":"10.1007","volume":"56","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4345-3515","authenticated-orcid":false,"given":"Nikolaus","family":"Buchmann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Fink","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina","family":"Tegeler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilja","family":"Demuth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriele","family":"Doblhammer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabeth","family":"Steinhagen-Thiessen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,5,22]]},"reference":[{"key":"1332_CR1","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jalz.2012.11.007","volume":"9","author":"M Prince","year":"2013","unstructured":"Prince M, Bryce R, Albanese E, Wimo A, Ribeiro W, Ferri CP (2013) The global prevalence of dementia: a systematic review and metaanalysis. Alzheimer\u2019s Dement 9:63\u201375.e62","journal-title":"Alzheimer\u2019s Dement"},{"key":"1332_CR2","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/jdi.12420","volume":"7","author":"ON Groeneveld","year":"2016","unstructured":"Groeneveld ON, Kappelle LJ, Biessels GJ (2016) Potentials of incretin-based therapies in dementia and stroke in type 2 diabetes mellitus. J Diabetes Investig 7:5\u201316","journal-title":"J Diabetes Investig"},{"key":"1332_CR3","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S1474-4422(05)70284-2","volume":"5","author":"GJ Biessels","year":"2006","unstructured":"Biessels GJ, Staekenborg S, Brunner E, Brayne C, Scheltens P (2006) Risk of dementia in diabetes mellitus: a systematic review. Lancet Neurol 5:64\u201374","journal-title":"Lancet Neurol"},{"key":"1332_CR4","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1111\/jdi.12087","volume":"4","author":"K Gudala","year":"2013","unstructured":"Gudala K, Bansal D, Schifano F, Bhansali A (2013) Diabetes mellitus and risk of dementia: a meta-analysis of prospective observational studies. J Diabetes Investig 4:640\u2013650","journal-title":"J Diabetes Investig"},{"key":"1332_CR5","doi-asserted-by":"crossref","first-page":"393","DOI":"10.3233\/JAD-161194","volume":"59","author":"GT Sutherland","year":"2017","unstructured":"Sutherland GT, Lim J, Srikanth V, Bruce DG (2017) Epidemiological approaches to understanding the link between type 2 diabetes and dementia. J Alzheimer\u2019s Dis 59:393\u2013403","journal-title":"J Alzheimer\u2019s Dis"},{"key":"1332_CR6","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1212\/WNL.0000000000002950","volume":"87","author":"W Li","year":"2016","unstructured":"Li W, Risacher SL, Huang E, Saykin AJ (2016) Type 2 diabetes mellitus is associated with brain atrophy and hypometabolism in the ADNI cohort. Neurology 87:595\u2013600","journal-title":"Neurology"},{"key":"1332_CR7","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1212\/WNL.44.7.1246","volume":"44","author":"M Breteler","year":"1994","unstructured":"Breteler M, Van Swieten J, Bots M, Grobbee D, Claus J, Van Den Hout J et al (1994) Cerebral white matter lesions, vascular risk factors, and cognitive function in a population-based study: the Rotterdam study. Neurology 44:1246\u20131246","journal-title":"Neurology"},{"key":"1332_CR8","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1136\/jnnp.74.1.70","volume":"74","author":"J Starr","year":"2003","unstructured":"Starr J, Wardlaw J, Ferguson K, MacLullich A, Deary I, Marshall I (2003) Increased blood\u2013brain barrier permeability in type II diabetes demonstrated by gadolinium magnetic resonance imaging. J Neurol Neurosurg Psychiatry 74:70\u201376","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1332_CR9","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s40200-017-0292-8","volume":"16","author":"M Tehrani-Doost","year":"2017","unstructured":"Tehrani-Doost M, Qavam SE, Arzaghi SM, Larijani B (2017) Association of diabetes mellitus and structural changes in the central nervous system in children and adolescents: a systematic review. J Diabetes Metab Disord 16:10","journal-title":"J Diabetes Metab Disord"},{"key":"1332_CR10","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.exger.2012.07.014","volume":"47","author":"LG Exalto","year":"2012","unstructured":"Exalto LG, Whitmer RA, Kappele LJ, Biessels GJ (2012) An update on type 2 diabetes, vascular dementia and Alzheimer\u2019s disease. Exp Gerontol 47:858\u2013864","journal-title":"Exp Gerontol"},{"key":"1332_CR11","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.2040-1124.2012.00234.x","volume":"3","author":"T Kawamura","year":"2012","unstructured":"Kawamura T, Umemura T, Hotta N (2012) Cognitive impairment in diabetic patients: Can diabetic control prevent cognitive decline? J Diabetes Investig 3:413\u2013423","journal-title":"J Diabetes Investig"},{"key":"1332_CR12","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s11892-014-0487-z","volume":"14","author":"T Ninomiya","year":"2014","unstructured":"Ninomiya T (2014) Diabetes mellitus and dementia. Curr Diabetes Rep 14:487","journal-title":"Curr Diabetes Rep"},{"key":"1332_CR13","doi-asserted-by":"crossref","first-page":"8281","DOI":"10.3390\/ijerph120708281","volume":"12","author":"O Ojo","year":"2015","unstructured":"Ojo O, Brooke J (2015) Evaluating the association between diabetes, cognitive decline and dementia. Int J Environ Res Public Health 12:8281\u20138294","journal-title":"Int J Environ Res Public Health"},{"key":"1332_CR14","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.biopsych.2009.02.013","volume":"67","author":"LA Profenno","year":"2010","unstructured":"Profenno LA, Porsteinsson AP, Faraone SV (2010) Meta-analysis of Alzheimer\u2019s disease risk with obesity, diabetes, and related disorders. Biol Psychiatry 67:505\u2013512","journal-title":"Biol Psychiatry"},{"key":"1332_CR15","doi-asserted-by":"crossref","first-page":"363","DOI":"10.2147\/VHRM.S1839","volume":"4","author":"E Duron","year":"2008","unstructured":"Duron E, Hanon O (2008) Vascular risk factors, cognitve decline, and dementia. Vasc Health Risk Manag 4:363","journal-title":"Vasc Health Risk Manag"},{"key":"1332_CR16","first-page":"CD003804","volume":"6","author":"A Areosa Sastre","year":"2017","unstructured":"Areosa Sastre A, Vernooij RWM, Gonz\u00e1lez-Cola\u00e7o Harmand M, Mart\u00ednez G (2017) Effect of the treatment of type 2 diabetes mellitus on the development of cognitive impairment and dementia. Cochrane Database Syst Rev 6:CD003804","journal-title":"Cochrane Database Syst Rev"},{"key":"1332_CR17","doi-asserted-by":"crossref","first-page":"349.e347349.e31","DOI":"10.1016\/j.jamda.2014.12.014","volume":"16","author":"AM Abbatecola","year":"2015","unstructured":"Abbatecola AM, Bo M, Barbagallo M, Incalzi RA, Pilotto A, Bellelli G et al (2015) Severe hypoglycemia is associated with antidiabetic oral treatment compared with insulin analogs in nursing home patients with type 2 diabetes and dementia: results from the DIMORA study. J Am Med Dir Assoc 16:349.e347\u2013349.e312","journal-title":"J Am Med Dir Assoc"},{"key":"1332_CR18","first-page":"317.e311317.e32","volume":"131","author":"O Yu","year":"2018","unstructured":"Yu O, Azoulay L, Yin H, Filion KB, Suissa S (2018) Sulfonylureas as initial treatment for type 2 diabetes and the risk of severe hypoglycemia. Am J Med 131:317.e311\u2013317.e322","journal-title":"Am J Med"},{"key":"1332_CR19","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1007\/s00125-018-4668-1","volume":"61","author":"AK Lee","year":"2018","unstructured":"Lee AK, Rawlings AM, Lee CJ, Gross AL, Huang ES, Sharrett AR et al (2018) Severe hypoglycaemia, mild cognitive impairment, dementia and brain volumes in older adults with type 2 diabetes: the Atherosclerosis Risk in Communities (ARIC) cohort study. Diabetologia 61:1956\u20131965","journal-title":"Diabetologia"},{"key":"1332_CR20","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1007\/s00125-017-4499-5","volume":"61","author":"C-H Lu","year":"2018","unstructured":"Lu C-H, Yang C-Y, Li C-Y, Hsieh C-Y, Ou H-T (2018) Lower risk of dementia with pioglitazone, compared with other second-line treatments, in metformin-based dual therapy: a population-based longitudinal study. Diabetologia 61:562\u2013573","journal-title":"Diabetologia"},{"issue":"18","key":"1332_CR21","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1212\/WNL.0000000000004586","volume":"89","author":"AR Orkaby","year":"2017","unstructured":"Orkaby AR, Cho K, Cormack J, Gagnon DR, Driver JA (2017) Metformin vs sulfonylurea use and risk of dementia in US veterans aged \u2265 65 years with diabetes. Neurology 89(18):1877\u20131885","journal-title":"Neurology"},{"key":"1332_CR22","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.peptides.2017.11.017","volume":"100","author":"VA Gault","year":"2018","unstructured":"Gault VA, H\u00f6lscher C (2018) GLP-1 receptor agonists show neuroprotective effects in animal models of diabetes. Peptides 100:101\u2013107","journal-title":"Peptides"},{"key":"1332_CR23","doi-asserted-by":"crossref","first-page":"807","DOI":"10.3233\/JAD-2009-1099","volume":"17","author":"DH Taylor Jr","year":"2009","unstructured":"Taylor DH Jr, Ostbye T, Langa KM, Weir D, Plassman BL (2009) The accuracy of Medicare claims as an epidemiological tool: the case of dementia revisited. J Alzheimer\u2019s Dis 17:807\u2013815","journal-title":"J Alzheimer\u2019s Dis"},{"key":"1332_CR24","doi-asserted-by":"crossref","first-page":"412","DOI":"10.4239\/wjd.v7.i17.412","volume":"7","author":"E Saedi","year":"2016","unstructured":"Saedi E, Gheini MR, Faiz F, Arami MA (2016) Diabetes mellitus and cognitive impairments. World J Diabetes 7:412\u2013422","journal-title":"World J Diabetes"},{"key":"1332_CR25","doi-asserted-by":"crossref","first-page":"300","DOI":"10.2337\/dc15-1588","volume":"39","author":"S Chatterjee","year":"2016","unstructured":"Chatterjee S, Peters SAE, Woodward M, Mejia Arango S, Batty GD, Beckett N et al (2016) Type 2 diabetes as a risk factor for dementia in women compared with men: a pooled analysis of 2.3 million people comprising more than 100,000 cases of dementia. Diabetes Care 39:300\u2013307","journal-title":"Diabetes Care"},{"key":"1332_CR26","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.ejphar.2008.02.049","volume":"585","author":"RP Kloppenborg","year":"2008","unstructured":"Kloppenborg RP, van den Berg E, Kappelle LJ, Biessels GJ (2008) Diabetes and other vascular risk factors for dementia: which factor matters most? A systematic review. Eur J Pharmacol 585:97\u2013108","journal-title":"Eur J Pharmacol"},{"key":"1332_CR27","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.jalz.2015.05.016","volume":"11","author":"M Baumgart","year":"2015","unstructured":"Baumgart M, Snyder HM, Carrillo MC, Fazio S, Kim H, Johns H (2015) Summary of the evidence on modifiable risk factors for cognitive decline and dementia: a population-based perspective. Alzheimer\u2019s Dement 11:718\u2013726","journal-title":"Alzheimer\u2019s Dement"},{"key":"1332_CR28","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1159\/000362201","volume":"42","author":"K Mehlig","year":"2014","unstructured":"Mehlig K, Skoog I, Waern M, Miao Jonasson J, Lapidus L, Bjorkelund C et al (2014) Physical activity, weight status, diabetes and dementia: a 34-year follow-up of the population study of women in Gothenburg. Neuroepidemiology 42:252\u2013259","journal-title":"Neuroepidemiology"},{"key":"1332_CR29","doi-asserted-by":"crossref","first-page":"e0187119","DOI":"10.1371\/journal.pone.0187119","volume":"12","author":"A Fink","year":"2017","unstructured":"Fink A, Buchmann N, Tegeler C, Steinhagen-Thiessen E, Demuth I, Doblhammer G (2017) Physical activity and cohabitation status moderate the link between diabetes mellitus and cognitive performance in a community-dwelling elderly population in Germany. PLoS One 12:e0187119","journal-title":"PLoS One"},{"key":"1332_CR30","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13195-017-0236-z","volume":"9","author":"Y-C Fan","year":"2017","unstructured":"Fan Y-C, Hsu J-L, Tung H-Y, Chou C-C, Bai C-H (2017) Increased dementia risk predominantly in diabetes mellitus rather than in hypertension or hyperlipidemia: a population-based cohort study. Alzheimers Res Ther 9:7","journal-title":"Alzheimers Res Ther"},{"key":"1332_CR31","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1212\/01.wnl.0000324925.95210.6d","volume":"71","author":"MS Beeri","year":"2008","unstructured":"Beeri MS, Schmeidler J, Silverman JM, Gandy S, Wysocki M, Hannigan CM et al (2008) Insulin in combination with other diabetes medication is associated with less Alzheimer neuropathology. Neurology 71:750\u2013757","journal-title":"Neurology"},{"key":"1332_CR32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3233\/JAD-189007","volume":"65","author":"JM Campbell","year":"2018","unstructured":"Campbell JM, Stephenson MD, Courten BD, Chapman I, Bellman SM, Aromataris E (2018) Metformin use associated with reduced risk of dementia in patients with diabetes: a systematic review and meta-analysis. J Alzheimer\u2019s Dis 65:1\u201312","journal-title":"J Alzheimer\u2019s Dis"},{"key":"1332_CR33","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1212\/01.WNL.0000140291.86406.D1","volume":"63","author":"WL Xu","year":"2004","unstructured":"Xu WL, Qiu CX, Wahlin \u00c5, Winblad B, Fratiglioni L (2004) Diabetes mellitus and risk of dementia in the Kungsholmen project. Neurology 63:1181","journal-title":"Neurology"},{"key":"1332_CR34","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1212\/01.WNL.0000129989.28404.9B","volume":"63","author":"R Peila","year":"2004","unstructured":"Peila R, Rodriguez BL, White LR, Launer LJ (2004) Fasting insulin and incident dementia in an elderly population of Japanese\u2013American men. Neurology 63:228\u2013233","journal-title":"Neurology"},{"key":"1332_CR35","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1212\/01.WNL.0000140292.04932.87","volume":"63","author":"JA Luchsinger","year":"2004","unstructured":"Luchsinger JA, Tang MX, Shea S, Mayeux R (2004) Hyperinsulinemia and risk of Alzheimer disease. Neurology 63:1187\u20131192","journal-title":"Neurology"},{"key":"1332_CR36","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0026-0495(90)90062-H","volume":"39","author":"M Laakso","year":"1990","unstructured":"Laakso M, Pyorala K (1990) Adverse effects of obesity on lipid and lipoprotein levels in insulin-dependent and non-insulin-dependent diabetes. Metabolism 39:117\u2013122","journal-title":"Metabolism"},{"key":"1332_CR37","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1212\/01.wnl.0000306313.89165.ef","volume":"71","author":"RA Whitmer","year":"2008","unstructured":"Whitmer RA, Gustafson DR, Barrett-Connor E, Haan MN, Gunderson EP, Yaffe K (2008) Central obesity and increased risk of dementia more than three decades later. Neurology 71:1057\u20131064","journal-title":"Neurology"},{"key":"1332_CR38","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1001\/archneurol.2008.582","volume":"66","author":"AL Fitzpatrick","year":"2009","unstructured":"Fitzpatrick AL, Kuller LH, Lopez OL, Diehr P, O\u2019Meara ES, Longstreth WT et al. (2009) Mid- and late-life obesity: risk of dementia in the cardiovascular health cognition study. Arch Neurol 66:336\u2013342","journal-title":"Arch Neurol"},{"key":"1332_CR39","doi-asserted-by":"crossref","first-page":"e0148908","DOI":"10.1371\/journal.pone.0148908","volume":"11","author":"S Kim","year":"2016","unstructured":"Kim S, Kim Y, Park SM (2016) Body mass index and decline of cognitive function. PLoS One 11:e0148908","journal-title":"PLoS One"},{"key":"1332_CR40","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1093\/aje\/kwu331","volume":"181","author":"E Albanese","year":"2015","unstructured":"Albanese E, Davis B, Jonsson PV, Chang M, Aspelund T, Garcia M et al (2015) Overweight and obesity in midlife and brain structure and dementia 26 years later: the AGES-Reykjavik study. Am J Epidemiol 181:672\u2013679","journal-title":"Am J Epidemiol"},{"key":"1332_CR41","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1016\/j.euroneuro.2014.03.002","volume":"24","author":"IAC Arnoldussen","year":"2014","unstructured":"Arnoldussen IAC, Kiliaan AJ, Gustafson DR (2014) Obesity and dementia: adipokines interact with the brain. Eur Neuropsychopharmacol 24:1982\u20131999","journal-title":"Eur Neuropsychopharmacol"},{"key":"1332_CR42","first-page":"165","volume":"8","author":"E Albanese","year":"2017","unstructured":"Albanese E, Launer LJ, Egger M, Prince MJ, Giannakopoulos P, Wolters FJ et al. (2017) Body mass index in midlife and dementia: systematic review and meta-regression analysis of 589,649 men and women followed in longitudinal studies. Alzheimer\u2019s Dement Diagn, Assess Dis Monit 8:165\u2013178","journal-title":"Alzheimer\u2019s Dement Diagn, Assess Dis Monit"},{"key":"1332_CR43","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1007\/s00125-017-4266-7","volume":"60","author":"S Yoon","year":"2017","unstructured":"Yoon S, Cho H, Kim J, Lee D-W, Kim GH, Hong YS et al (2017) Brain changes in overweight\/obese and normal-weight adults with type 2 diabetes mellitus. Diabetologia 60:1207\u20131217","journal-title":"Diabetologia"},{"key":"1332_CR44","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.nicl.2017.07.004","volume":"16","author":"A Nouwen","year":"2017","unstructured":"Nouwen A, Chambers A, Chechlacz M, Higgs S, Blissett J, Barrett TG et al (2017) Microstructural abnormalities in white and gray matter in obese adolescents with and without type 2 diabetes. NeuroImage Clin 16:43\u201351","journal-title":"NeuroImage Clin"},{"key":"1332_CR45","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.maturitas.2014.05.009","volume":"79","author":"S Bennett","year":"2014","unstructured":"Bennett S, Thomas AJ (2014) Depression and dementia: cause, consequence or coincidence? Maturitas 79:184\u2013190","journal-title":"Maturitas"},{"key":"1332_CR46","doi-asserted-by":"crossref","first-page":"e1002265","DOI":"10.1371\/journal.pmed.1002265","volume":"14","author":"S Schilling","year":"2017","unstructured":"Schilling S, Tzourio C, Soumar\u00e9 A, Kaffashian S, Dartigues J-F, Ancelin M-L et al (2017) Differential associations of plasma lipids with incident dementia and dementia subtypes in the 3C study: a longitudinal, population-based prospective cohort study. PLoS Med 14:e1002265","journal-title":"PLoS Med"},{"key":"1332_CR47","doi-asserted-by":"crossref","first-page":"642","DOI":"10.2174\/15672050113109990037","volume":"10","author":"RO Akinyemi","year":"2013","unstructured":"Akinyemi RO, Mukaetova-Ladinska EB, Attems J, Ihara M, Kalaria RN (2013) Vascular risk factors and neurodegeneration in ageing related dementias: Alzheimer\u2019s disease and vascular dementia. Curr Alzheimer Res 10:642\u2013653","journal-title":"Curr Alzheimer Res"},{"key":"1332_CR48","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1016\/j.bbadis.2014.06.010","volume":"1842","author":"DA Butterfield","year":"2014","unstructured":"Butterfield DA, Di Domenico F, Barone E (2014) Elevated risk of type 2 diabetes for development of Alzheimer disease: a key role for oxidative stress in brain. Biochim et Biophys Acta 1842:1693\u20131706","journal-title":"Biochim et Biophys Acta"},{"key":"1332_CR49","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.sjbs.2014.05.003","volume":"22","author":"G Mushtaq","year":"2015","unstructured":"Mushtaq G, Khan JA, Kumosani TA, Kamal MA (2015) Alzheimer\u2019s disease and type 2 diabetes via chronic inflammatory mechanisms. Saudi J Biol Sci 22:4\u201313","journal-title":"Saudi J Biol Sci"},{"key":"1332_CR50","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/01.JGP.0000310778.20870.ae","volume":"16","author":"KJ Anstey","year":"2008","unstructured":"Anstey KJ, Lipnicki DM, Low LF (2008) Cholesterol as a risk factor for dementia and cognitive decline: a systematic review of prospective studies with meta-analysis. Am J Geriatr Psychiatry 16:343\u2013354","journal-title":"Am J Geriatr Psychiatry"},{"issue":"Suppl 3","key":"1332_CR51","doi-asserted-by":"crossref","first-page":"S315","DOI":"10.3233\/JAD-132366","volume":"42","author":"S Giannopoulos","year":"2014","unstructured":"Giannopoulos S, Katsanos AH, Kosmidou M, Tsivgoulis G (2014) Statins and vascular dementia: a review. J Alzheimer\u2019s Dis 42(Suppl 3):S315\u2013S320","journal-title":"J Alzheimer\u2019s Dis"}],"container-title":["Acta Diabetologica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-019-01332-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00592-019-01332-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-019-01332-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,18]],"date-time":"2024-07-18T11:52:02Z","timestamp":1721303522000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00592-019-01332-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,22]]},"references-count":51,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["1332"],"URL":"https:\/\/doi.org\/10.1007\/s00592-019-01332-7","relation":{},"ISSN":["0940-5429","1432-5233"],"issn-type":[{"type":"print","value":"0940-5429"},{"type":"electronic","value":"1432-5233"}],"subject":[],"published":{"date-parts":[[2019,5,22]]},"assertion":[{"value":"31 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Dr. Steinhagen-Thiessen reports grants and personal fees from Sanofi, personal fees from MSD, Fresenius, personal fees from Amgen and Chiesi, outside the submitted work. Dr. Demuth reports grants from Sanofi, personal fees from uniQure biopharma B.V., outside the submitted work. Prof. Doblhammer-Reiter recieved honoraries from Eli Lilly and Novartis not related to the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study involving retrospective, anonymized claims data falls outside the scope of the Declaration of Helsinki and did not require ethical review.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and animal rights disclosure"}},{"value":"For this type of study formal consent is not required.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}